NEW YORK, Feb. 20, 2017 -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Gigamon Inc. securities (NYSE:GIMO) from October 27, 2016 through January 17, 2017, inclusive (the “Class Period”). The lawsuit seeks to recover damages for Gigamon investors under the federal securities laws.
To join the Gigamon class action, go to http://rosenlegal.com/cases-1041.html or call Phillip Kim, Esq. or Kevin Chan, Esq. toll-free at 866-767-3653 or email [email protected] or [email protected] for information on the class action.
NO CLASS HAS YET BEEN CERTIFIED IN THE ABOVE ACTION. UNTIL A CLASS IS CERTIFIED, YOU ARE NOT REPRESENTED BY COUNSEL UNLESS YOU RETAIN ONE. YOU MAY ALSO REMAIN AN ABSENT CLASS MEMBER AND DO NOTHING AT THIS POINT. YOU MAY RETAIN COUNSEL OF YOUR CHOICE.
According to the lawsuit, throughout the Class Period Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about Gigamon’s business, operations, and prospects, including that: (1) Gigamon was experiencing reduced product bookings in its North America West region; (2) several of Gigamon’s significant customers were deferring purchasing decisions into 2017; (3) Gigamon failed to properly include these trends in its financial guidance; and (4) as a result, Defendants’ statements about Gigamon’s business, operations, and prospects, including statements about its revenue guidance, were false and misleading and/or lacked a reasonable basis. When the true details entered the market, the lawsuit claims that investors suffered damages.
A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than March 28, 2017. A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation. If you wish to join the litigation, go to http://rosenlegal.com/cases-1041.html or to discuss your rights or interests regarding this class action, please contact Phillip Kim, Esq. or Kevin Chan, Esq. of Rosen Law Firm toll free at 866-767-3653 or via e-mail at [email protected] or [email protected].
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm.
Rosen Law Firm represents investors throughout the globe, concentrating its practice in securities class actions and shareholder derivative litigation.
Contact Information: Laurence Rosen, Esq. Phillip Kim, Esq. Kevin Chan, Esq. The Rosen Law Firm, P.A. 275 Madison Avenue, 34th Floor New York, NY 10016 Tel: (212) 686-1060 Toll Free: (866) 767-3653 Fax: (212) 202-3827 [email protected] [email protected] [email protected] www.rosenlegal.com


Tokyo Electric Power Attracts Major Investors Amid Billion-Dollar Restructuring Push
Baker Hughes Sells Waygate Technologies to Hexagon for $1.45 Billion
Bendigo and Adelaide Bank Posts Strong Q3 Earnings, Announces AI-Driven Job Cuts
Anthropic's Mythos AI Model Sparks Emergency Cybersecurity Meeting With Top U.S. Bank CEOs
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG
Volkswagen Q1 2026 Sales Decline Amid China and U.S. Market Pressures
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth
MATCH Act: How New U.S. Chip Legislation Could Freeze China's Semiconductor Ambitions
TSMC Posts Record Q1 2026 Profits Driven by Surging AI Chip Demand
OpenAI Addresses Security Vulnerability in macOS App Certification Process
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts
Jefferies Upgrades Starbucks to Hold as China JV Deal Closes and U.S. Business Shows Signs of Recovery
Bill Ackman Eyes New Fund to Bet Against Market Complacency
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes
Abbott Laboratories Ordered to Pay $53 Million in Premature Infant Formula Lawsuit
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 



